Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Phreesia, Inc. Common Stock (NY:PHR)

29.76 +1.00 (+3.48%)
Streaming Delayed Price Updated: 11:13 AM EDT, Aug 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Phreesia, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Phreesia and Sesame Workshop Announce 5-Year Collaboration to Improve the Health of Millions of Children Through the Power of Sesame Street
From Phreesia, Inc.
Via Business Wire
Phreesia Named to the 2025 Capterra Shortlist for Patient Engagement and Medical Scheduling
From Phreesia, Inc.
Via Business Wire
Phreesia Sets Release Date for Fiscal Second Quarter 2026 Results
From Phreesia, Inc.
Via Business Wire
Where Phreesia Stands With Analysts
 
Via Benzinga
What to Expect from Phreesia's Earnings
 
Via Benzinga
New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication
From Phreesia, Inc.
Via Business Wire
3 Red-Hot Growth Stocks to Buy in 2025
Via The Motley Fool
Topics Retirement
What 4 Analyst Ratings Have To Say About Phreesia
 
Via Benzinga
Phreesia Named in Black Book Research’s List of 2025’s Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management
From Phreesia, Inc.
Via Business Wire
Becker’s Names Phreesia’s Kristin Roberts as one of 2025’s 100 Women in Health IT to Know
From Phreesia, Inc.
Via Business Wire
Q1 Earnings Outperformers: Phreesia (NYSE:PHR) And The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Phreesia (NYSE:PHR) and its peers. 
Via StockStory
PHR Q1 Earnings Call: Profitability Surges Amid Product Expansion
Healthcare technology company Phreesia (NYSE:PHR) exceeded Wall Street’s revenue expectations in Q1 CY2025, as sales rose 14.5% year on year to $115.9 million. Its GAAP loss of $0.07 per share... 
Via StockStory
Topics Artificial Intelligence
PHR Q1 Earnings Call: Revenue Misses, Profitability Surges Amid Product Expansion
Healthcare technology company Phreesia (NYSE:PHR) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 14.5% year on year to $115.9 million. Its GAAP loss of $0.07 per share increased... 
Via StockStory
Topics Artificial Intelligence
Phreesia (NYSE:PHR) Surprises With Q1 Sales
Healthcare technology company Phreesia (NYSE:PHR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 14.5% year on year to $115.9 million. The company expects the... 
Via StockStory
Phreesia Announces First Quarter Fiscal 2026 Results
From Phreesia, Inc.
Via Business Wire
Earnings Scheduled For May 28, 2025
 
Via Benzinga
Phreesia (PHR) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
3 of Wall Street’s Favorite Stocks Skating on Thin Ice
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Phreesia Updates May 28, 2025, Earnings Release Information for Fiscal First Quarter 2026 Results
From Phreesia, Inc.
Via Business Wire
1 Cash-Heavy Stock with Impressive Fundamentals and 2 to Ignore
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,... 
Via StockStory
Phreesia Sets Release Date for Fiscal First Quarter 2026 Results
From Phreesia, Inc.
Via Business Wire
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and... 
Via StockStory
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and... 
Via StockStory
Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (NASDAQ:PINC) and its peers. 
Via StockStory
Topics Economy
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season. 
Via StockStory
Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers. 
Via StockStory
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season. 
Via StockStory
4 Analysts Have This To Say About Phreesia
 
Via Benzinga
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
1 Healthcare Stock with Exciting Potential and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.